iPSC-derived Neuron and Neural Progenitor Cell (NPC) Generation Services
Human neurons and neural progenitor cells (NPCs) are invaluable models and useful tools for disease mechanism exploration and drug screening. However, obtaining those primary cells poses several challenges, including ethical considerations, limited availability of human tissue, and the difficulty of isolating and maintaining these cells in vitro. The advent of induced pluripotent stem cells (iPSCs) reprogramming technology has overcome this limitation, making the generation of various neurons both easy and efficient. Leveraging our expertise in this cutting-edge field, we are proud to offer researchers the iPSC-derived neurons and neural progenitor cells that facilitate groundbreaking studies in neuroscience.
What We Can Provide
iPSC-derived GABAergic Neuron Generation | iPSC-derived Glutamatergic Neuron Generation |
iPSC-derived Cortical Neuron Generation | iPSC-derived Motor Neuron Generation |
Overview of iPSC Technology
iPSCs are somatic cells reprogrammed to an embryonic stem cell-like state through the introduction of specific transcription factors. The resulting iPSCs retain the ability to differentiate into nearly any cell type in the body, including neurons and neural progenitor cells, which serve as the precursors for mature neurons. By providing a renewable source of these specialized cells, iPSC technology offers significant advantages over traditional methods, such as the use of embryonic stem cells or primary neurons, which can be limited in availability and ethical considerations.
Derivation of Neurons and Neural Progenitor Cells
The process of generating neurons and NPCs from iPSCs typically involves several stages:
1. Reprogramming Somatic cells (e.g., skin or blood cells) are collected and reprogrammed into iPSCs using defined factors, usually via viral or non-viral methods. This step is crucial as it ensures the pluripotency of the derived cells. |
2. Differentiation Once established, iPSCs are directed to differentiate into neural progenitor cells through the application of specific signaling molecules and growth factors in a controlled environment. This often mimics the natural conditions found during early brain development. |
3. Maturation Neural progenitor cells can further differentiate into mature neurons or glial cells. This maturation process involves the induction of neuronal identity through various biochemical cues and may require several weeks to months for the cells to reach functional maturity. |
Fig.1 NPCs were derived from iPSCs, and these NPCs were subsequently induced to differentiate into neurons.1
Applications and Importance
- Disease Modeling
hiPSC-derived neurons and NPCs play a pivotal role in advancing neurological research and drug discovery. Their ability to model neurological diseases, such as Alzheimer's and Parkinson's, provides invaluable insights into disease mechanisms and potential therapeutic targets.
- Drug Screening
Furthermore, hiPSC-derived neurons and NPCs enable high-throughput screening of drug candidates, facilitating the identification of neuroprotective compounds. Their use in cellular therapies holds promise for regenerative medicine, potentially offering new treatments for neurodegenerative disorders.
Contact Us Today
Unlock the potential of hiPSC-derived neurons for your research needs. Contact us today to learn more about our services and how we can support your research goals.
Reference
- Kang, S., Chen, X., Gong, S. et al. "Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern". Sci Rep 7, 12233 (2017), Distributed under CC BY 4.0, without modification.
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody (NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)